Related references
Note: Only part of the references are listed.Sent to Destroy The Ubiquitin Proteasome System Regulates Cell Signaling and Protein Quality Control in Cardiovascular Development and Disease
Monte S. Willis et al.
CIRCULATION RESEARCH (2010)
Apoptotic and non-apoptotic programmed cardiomyocyte death in ventricular remodelling
Gerald W. Dorn
CARDIOVASCULAR RESEARCH (2009)
ASK1 Regulates Cardiomyocyte Death but Not Hypertrophy in Transgenic Mice
Qinghang Liu et al.
CIRCULATION RESEARCH (2009)
Protein Kinase Cα, but Not PKCβ or PKCγ, Regulates Contractility and Heart Failure Susceptibility Implications for Ruboxistaurin as a Novel Therapeutic Approach
Qinghang Liu et al.
CIRCULATION RESEARCH (2009)
Pathological and physiological hypertrophies are regulated by distinct gene programs
Vidar Beisvag et al.
EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION (2009)
Cdc42 is an antihypertrophic molecular switch in the mouse heart
Marjorie Maillet et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
α1G-dependent T-type Ca2+ current antagonizes cardiac hypertrophy through a NOS3-dependent mechanism in mice
Hiroyuki Nakayama et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
CaMKII and a failing strategy for growth in heart
Mark E. Anderson
JOURNAL OF CLINICAL INVESTIGATION (2009)
Requirement for Ca2+/calmodulin-dependent kinase II in the transition from pressure overload-induced cardiac hypertrophy to heart failure in mice
Haiyun Ling et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
S100A1 in cardiovascular health and disease: Closing the gap between basic science and clinical therapy
Carolin Kraus et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2009)
The many roles of histone deacetylases in development and physiology: implications for disease and therapy
Michael Haberland et al.
NATURE REVIEWS GENETICS (2009)
The δ isoform of CaM kinase II is required for pathological cardiac hypertrophy and remodeling after pressure overload
Johannes Backs et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Quantitative control of adaptive cardiac hypertrophy by acetyltransferase p300
Jian Qin Wei et al.
CIRCULATION (2008)
Molecular regulation of cardiac hypertrophy
Sean P. Barry et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2008)
NFATc2 is a necessary mediator of calcineurin-dependent cardiac hypertrophy and heart failure
Meriem Bourajjaj et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Insulin-Like Growth Factor I Receptor Signaling Is Required for Exercise-Induced Cardiac Hypertrophy
Jaetaek Kim et al.
MOLECULAR ENDOCRINOLOGY (2008)
Myocardial matrix remodeling and the matrix metalloproteinases: Influence on cardiac form and function
Francis G. Spinale
PHYSIOLOGICAL REVIEWS (2007)
The MEK/ERK cascade: From signaling specificity to diverse functions
Yoav D. Shaul et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2007)
p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload
Masanori Sano et al.
NATURE (2007)
Hdac2 regulates the cardiac hypertrophic response by modulating Gsk3β activity
Chinmay M. Trivedi et al.
NATURE MEDICINE (2007)
Cardiac S100A1 protein levels determine contractile performance and propensity toward heart failure after myocardial infarction
Patrick Most et al.
CIRCULATION (2006)
Pharmacological- and gene therapy-based inhibition of protein kinase Cα/β enhances cardiac contractility and attenuates heart failure
Michael Hambleton et al.
CIRCULATION (2006)
Targeted deletion of Puma attenuates cardiomyocyte death and improves cardiac function during ischemia-reperfusion
Ambrus Toth et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
Intermittent pressure overload triggers hypertrophy-independent cardiac dysfunction and vascular rarefaction
Cinzia Perrino et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Akt1 is required for physiological cardiac growth
B DeBosch et al.
CIRCULATION (2006)
Vascular endothelial growth factor blockade promotes the transition from compensatory cardiac hypertrophy to failure in response to pressure overload
Y Izumiya et al.
HYPERTENSION (2006)
Targeted deletion of matrix metalloproteinase 2 ameliorates myocardial remodeling in mice with chronic pressure overload
H Matsusaka et al.
HYPERTENSION (2006)
From left ventricular hypertrophy to congestive heart failure: Management of hypertensive heart disease
AH Gradman et al.
PROGRESS IN CARDIOVASCULAR DISEASES (2006)
Histone acetyltransferase activity of p300 is required for the promotion of left ventricular remodeling after myocardial infarction in adult mice in vivo
S Miyamoto et al.
CIRCULATION (2006)
Controversies in Cardiology 4 - Controversies in ventricular remodelling
LH Opie et al.
LANCET (2006)
Distinct pathways regulate proapoptotic Nix and BNip3 in cardiac stress
AS Gálvez et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Putting the brakes on cardiac hypertrophy - Exploiting the NO-cGMP counter-regulatory system
GW Booz
HYPERTENSION (2005)
Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy
E Takimoto et al.
NATURE MEDICINE (2005)
cGMP catabolism by phosphodiesterase 5A regulates cardiac adrenergic stimulation by NOS3-dependent mechanism
E Takimoto et al.
CIRCULATION RESEARCH (2005)
Nuclear targeting of Akt enhances kinase activity and survival of cardiomyocytes
I Shiraishi et al.
CIRCULATION RESEARCH (2004)
PKC-α regulates cardiac contractility and propensity toward heart failure
JC Braz et al.
NATURE MEDICINE (2004)
Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy
BJ Wilkins et al.
CIRCULATION RESEARCH (2004)
The RAF proteins take centre stage
C Wellbrock et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2004)
Expression of constitutively active guanylate cyclase in cardiomyocytes inhibits the hypertrophic effects of isoproterenol and aortic constriction on mouse hearts
A Zahabi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Reinduction of T-type calcium channels by endothelin-1 in failing hearts in vivo and in adult rat ventricular myocytes in vitro
T Izumi et al.
CIRCULATION (2003)
Phosphoinositide 3-kinase(p110α) plays a critical role for the induction of physiological, but not pathological, cardiac hypertrophy
JR McMullen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
c-Jun N-terminal kinases (JNK) antagonize cardiac growth through cross-talk with calcineurin-NFAT signaling
QR Liang et al.
EMBO JOURNAL (2003)
The δC isoform of CaMKII is activated in cardiac hypertrophy and induces dilated cardiomyopathy and heart failure
T Zhang et al.
CIRCULATION RESEARCH (2003)
Targeted inhibition of p38 MAPK promotes hypertrophic cardiomyopathy through upregulation of calcineurin-NEAT signaling
JC Braz et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Cardiac p300 is involved in myocyte growth with decompensated heart failure
T Yanazume et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Pressure-independent enhancement of cardiac hypertrophy in atrial natriuretic peptide-deficient mice
JA Feng et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2003)
Targeted disruption of NFATc3, but not NFATc4, reveals an intrinsic defect in calcineurin-mediated cardiac hypertrophic growth
BJ Wilkins et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Akt induces enhanced myocardial contractility and cell size in vivo in transgenic mice
G Condorelli et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy
CL Zhang et al.
CELL (2002)
Inhibition of calcineurin-NFAT hypertrophy signaling by cGMP-dependent protein kinase type I in cardiac myocytes
B Fiedler et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Phenotypic spectrum caused by transgenic overexpression of activated Akt in the heart
T Matsui et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Angiotensin II receptor blockade does not improve left ventricular function and remodeling in subacute mitral regurgitation in the dog
GJ Perry et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2002)
Impaired cardiac hypertrophic response in calcineurin Aβ-deficient mice
OF Bueno et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Impaired cardiac contractility response to hemodynamic stress in S100A1-deficient mice
XJ Du et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Activated MEK5 induces serial assembly of sarcomeres and eccentric cardiac hypertrophy
RL Nicol et al.
EMBO JOURNAL (2001)
The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice
OF Bueno et al.
EMBO JOURNAL (2000)
Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction
A Ducharme et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
The conserved phosphoinositide 3-kinase pathway determines heart size in mice
T Shioi et al.
EMBO JOURNAL (2000)
Cardiac remodeling-concepts and clinical implications: A consensus paper from an international forum on cardiac remodeling
JN Cohn et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2000)
Share Paper
